Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

1(50.0%)

N/A

1(50.0%)

2Total

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05024734Phase 2Recruiting

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

Role: collaborator

NCT04550156Not ApplicableCompleted

Evaluation of the Introduction of a Colorectal Bundle in Left Sided Colorectal Resections

Role: collaborator

NCT04763538Recruiting

Quality and Outcome Measurements of Urological Patients

Role: collaborator

NCT00696605Completed

Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion

Role: lead

NCT01305785Unknown

AMIS Plus - National Registry of Acute Myocardial Infarction in Switzerland

Role: collaborator

All 5 trials loaded